Why the study?
Do nicardipine prolonged-release implants improve functional outcome and quality of life in patients with aneurysmal subarachnoid hemorrhage?
Do nicardipine prolonged-release implants improve functional outcome and quality of life in patients with aneurysmal subarachnoid hemorrhage?
While nicardipine prolonged-release implants improve some functional outcomes after aSAH, overall quality of life appears to be dictated by the severity of the hemorrhage itself rather than the treatment.
No takes yet. Share an insight, caveat, or question.
NPRI may confer modest functional gains after aSAH without QoL benefit; leaves open whether randomized trials are needed.
Barth et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: